- Doctors Describe Texas Dairy Farm Worker’s Case of Bird Flu
- Does Preschool Boost Kids’ Long-Term Academic Success? Study Finds Mixed Results
- AI Might Spot Rare Diseases in Patients Years Earlier
- An Orangutan Healed Himself With Medicinal Plant
- Quit-Smoking Meds Not Working for You? Try Upping the Dose
- Fewer Americans Are Suffering Most Dangerous Form of Heart Attack
- Even Skipping Meat for One Meal Helps Liver Disease Patients
- You May Not Have to Fast Before Catheter-Based Heart Test, Study Suggests
- EPA Earmarks $3 Billion to Replace Lead Pipes Nationwide
- Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits
U.S. Hospitals Are Facing Shortage of Dye Needed for Life-Saving Scans
U.S. hospitals are running low on contrast dye injected into patients undergoing enhanced X-rays, CT scans and MRIs.
The fluid, which makes the routine but potentially life-saving scans readable, helps doctors identify clots in the heart and brain. The shortage is expected to last until at least June 30, the American Hospital Association (AHA) says.
It’s a result of COVID-19 pandemic-related factory closures in Shanghai, China, where most of the world’s supply is made, according to CBS News.
GE Healthcare is the main U.S. supplier of contrast fluid, called Omnipaque.
The AHA has asked the company for more information on the shortage, saying hospitals rely on a consistent supply to diagnose and treat a wide range of patients, including those with life-threatening conditions.
“It is too easy for us to take for granted the readily available supply of something that is so important to our patients and our radiologic practices until it’s gone,” Dr. Thomas Grist said in a news release from the Radiological Society of North America. He’s the author on a new report on the issue published online May 19 in Radiology.
“We need to commit to changing the supply chain so that a single event in a faraway country does not put us in this predicament again,” said Grist, who is chair of the department of radiology at the University of Wisconsin School of Medicine and Public Health in Madison. “We owe it to our patients who trust us with their lives and well-being every day of the year.”
The dye is being “aggressively” rationed at the University of Alabama at Birmingham Health System and some elective imaging procedures are being delayed.
“We need to make sure we have IV contrast available for the patients in critical need,” health system CEO Dr. Selwyn Vickers told CBS News.
The health system’s supply of dye will be reserved for “life-or-death matters,” he said.
The University of Kansas Health System’s use of the dye is being limited to critically ill patients, according to Dr. Phil Johnson, chief of radiology.
“We had to triage and limit the use of contrast dye to only critically ill patients that had to have contrast dye either to establish a diagnosis, or to guide a life-saving or a limb-sparing treatment,” he told CBS News.
More information
The American Hospital Association has more about the shortage of contrast dye.
SOURCES: CBS News; Radiological Society of North America, news release, May 19, 2022; University of Alabama at Birmingham, news release, May 7, 2022
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.